Drug Type Small molecule drug |
Synonyms DuP 734, DUP 734 |
Action antagonists |
Mechanism 5-HT2 receptor antagonists(Serotonin 2 (5-HT2) receptor antagonists), σ1 receptor antagonists(Sigma opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H23BrFNO |
InChIKeyQLZIAKMYJFJBKA-UHFFFAOYSA-N |
CAS Registry135135-87-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Behavioural disorders | Phase 1 | - | - | |
Psychotic Disorders | Phase 1 | United States | - |